Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2004-01-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM030858+PMID 14736257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

  2002cited by this paper
• Bis(acetato)amminedichloro(cyclohexylamine)platinum(IV), an orally active anticancer drug.

  1995cited by this paper
• The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.

  1991cited by this paper

• Research Progress of Platinum-Based Complexes in Lung Cancer Treatment: Mechanisms, Applications, and Challenges

  2025cites this paper
• Applications of Bridgehead Heterocycles in Drug Design and Medicinal Chemistry

  2025cites this paper
• Inhibition of Chk1 stimulates cytotoxic action of platinum-based drugs and TRAIL combination in human prostate cancer cells

  2024cites this paper
• Homo and heterometallic ruthenium and platinum complexes with multiple targets for therapeutic applications: a review

  2023cites this paper
• Platinum-Based Drugs in Cancer Treatment: Expanding Horizons and Overcoming Resistance

  2023cites this paper
• Potential Anticancer Activities and Catalytic Oxidation Efficiency of Platinum(IV) Complex

  2022cites this paper
• Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy

  2022cites this paper
• Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance

  2022cites this paper
• Research progress of azido-containing Pt(IV) antitumor compounds.

  2021cites this paper
• Supramolecular Coronation of Platinum(II) Complexes by Macrocycles: Structure, Relativistic DFT Calculations, and Biological Effects.

  2021cites this paper
• Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity

  2021cites this paper
• Rational design of anticancer platinum(IV) prodrugs

  2020cites this paper
• Multifunctional, heterometallic ruthenium-platinum complexes with medicinal applications

  2019cites this paper
• Current Status for Oral Platinum (IV) Anticancer Drug Development

  2018cites this paper
• Stimuli-Responsive Therapeutic Metallodrugs.

  2018cites this paper
• Anticancer platinum‐based complexes with non‐classical structures

  2018cites this paper
• Insights from Computations on the Mechanism of Reduction by Ascorbic Acid of PtIV Prodrugs with Asplatin and Its Chlorido and Bromido Analogues as Model Systems.

  2018cites this paper
• Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands

  2018cites this paper
• Research progress in modern structure of platinum complexes.

  2017cites this paper
• Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.

  2017cites this paper
• Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells

  2017cites this paper
• A spectroscopic investigation into the binding of novel platinum(IV) and platium(II) anticancer drugs with DNA

  2017cites this paper
• Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10

  2017cites this paper
• A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity.

  2016cites this paper
• Pharmacokinetics and tissue distribution of two novel isomerism anticancer platinum compounds

  2016cites this paper
• Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

  2016cites this paper
• New trends in platinum and palladium complexes as antineoplastic agents

  2016cites this paper
• Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.

  2015cites this paper
• Recent Advances in Platinum (IV) Complex‐Based Delivery Systems to Improve Platinum (II) Anticancer Therapy

  2015cites this paper
• Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells

  2015cites this paper
• Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.

  2014cites this paper
• A new entry to asymmetric platinum(IV) complexes via oxidative chlorination.

  2014cites this paper
• Improvements in the Synthesis and Understanding of the Iodo-bridged Intermediate en Route to the Pt(IV) Prodrug Satraplatin.

  2014cites this paper
• Metabonomics study on nephrotoxicity induced by intraperitoneal and intravenous cisplatin administration using rapid resolution liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry (RRLC-Q-TOF-MS)

  2014cites this paper
• Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs.

  2014cites this paper
• Synthesis and Characterization of 3s,5s,7s-Adamantan-1-Amine Complexes with Metals of Biological Interest

  2014cites this paper
• The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

  2013cites this paper
• Higher anti‐tumour efficacy of platinum(IV) complex LA‐12 is associated with its ability to bypass M‐phase entry block induced in oxaliplatin‐treated human colon cancer cells

  2013cites this paper
• Bulky N(,N)-(di)alkylethane-1,2-diamineplatinum(II) compounds as precursors for generating unsymmetrically substituted platinum(IV) complexes.

  2013cites this paper
• From amino acids to proteins as targets for metal-based drugs.

  2012cites this paper
• Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.

  2012cites this paper
• Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.

  2012cites this paper
• Catalytic Electrochemical Analysis of Platinum in Pt-DNA Adducts

  2012cites this paper
• Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate.

  2012cites this paper
• Conception de nouveaux bioconjugués "squalénisés" anticancéreux dotés de propriétés d'auto-assemblage : synthèse, caractérisation des nanoparticules et évaluation biologique

  2011cites this paper
• Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes.

  2011cites this paper
• The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo

  2011cites this paper
• New Trends and Future Developments of Platinum‐Based Antitumor Drugs

  2011cites this paper
• A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis(acetato)amminedichlo

  2011cites this paper
• Anticancer platinum (IV) prodrugs with novel modes of activity.

  2011cites this paper
• Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.

  2010cites this paper
• The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12

  2010cites this paper
• The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin

  2010cites this paper
• Unusual DNA binding modes for metal anticancer complexes.

  2009cites this paper
• MECHANISMS OF EFFECTS OF PLATINUM ( II ) AND ( IV ) COMPLExES . COMPARISON OF CISPLATIN AND OxALIPLATIN wITH SATRAPLATIN AND LA-12 , NEw PT ( IV )-BASED DRUGS

  2009cites this paper
• The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin

  2008cites this paper
• Amorphous form of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) amminedichloroplatinum (IV)

  2008cites this paper
• Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism

  2008cites this paper
• MECHANISMS OF EFFECTS OF PLATINUM (II) AND (IV) COMPLExES. COMPARISON OF CISPLATIN AND OxALIPLATIN wITH SATRAPLATIN AND LA-12, NEw PT(IV)-BASED DRUGS. A MINIREVIEw

  2008cites this paper
• Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity.

  2008cites this paper
• Preparation, characterization and in vitro anticancer activity of platinum(II) complexes with N-Cyclohexyl-1,3-propanediamine as the carrier.

  2008cites this paper
• Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in the tumor tissue.

  2007cites this paper
• A Suggestion of Electrochemical Biosensor for Study of Platinum(II)‐DNA Interactions

  2007cites this paper
• Basis for design and development of platinum(IV) anticancer complexes.

  2007cites this paper
• Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex.

  2007cites this paper
• Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin

  2007cites this paper
• High effectiveness of platinum complexes with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro PhD Thesis

  2006cites this paper
• More pronounced salt dependence and higher reactivity for platination of the hairpin r(CGCGUUGUUCGCG) compared with d(CGCGTTGTTCGCG)

  2006cites this paper
• An Entry to Novel Platinum Complexes: Carboxylation of Dihydroxoplatinum(IV) Complexes with Succinic Anhydride and Subsequent Derivatization

  2006cites this paper
• Other Novel Therapies

  2006cites this paper
• Recent developments in antitumour platinum coordination compounds

  2006cites this paper
• Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.

  2006cites this paper
• Comparative anti-tumor efficacy of two orally administered platinum(IV) drugs in nude mice bearing human tumor xenografts

  2006cites this paper
• Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

  2005cites this paper
• 29 Metal complexes as pharmaceuticals

  2005cites this paper
• Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-12

  2005cites this paper
• High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.

  2005cites this paper
• In vitro anticancer activities and optical imaging of novel intercalative non-cisplatin conjugates.

  2005cites this paper
• Pharmacokinetics and tissue distribution of platinum in rats following single and multiple oral doses of LA-12 [(OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)].

  2005cites this paper
• New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes

  2004cites this paper
• Single-dose pharmacokinetics of a novel oral platinum cytostatic drug ([OC-6-43]-bis[acetato][1-adamantylamine]amminedichloroplatinum [IV]) in pigs.

  2004cites this paper
• Characterization of novel nitroplatinum(iv) complexes for the treatment of cancer

  2004cites this paper